Duloxetine overdose causes sympathomimetic and serotonin toxicity without major complications

References

• Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, et al. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology. 2001;25(6):871–880.
   PubMed Web of Science ®Google Scholar
• Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev. 2014;3(1):CD007115.
   Google Scholar
• Derby MA, Zhang L, Chappell JC, et al. The effects of supratherapeutic doses of duloxetine on blood pressure and pulse rate. J Cardiovasc Pharmacol. 2007;49(6):384–393.
   PubMedGoogle Scholar
• Brunton S, Wang F, Edwards SB, et al. Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies. Drug Saf. 2010;33(5):393–407.
   PubMed Web of Science ®Google Scholar
• Vuppalanchi R, Hayashi PH, Chalasani N, Drug-Induced Liver Injury Network (DILIN), et al. Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network. Aliment Pharmacol Ther. 2010;32(9):1174–1183.
   PubMedGoogle Scholar
• Darracq MA, Clark A, Qian L, et al. A retrospective review of isolated duloxetine-exposure cases. Clin Toxicol (Phila). 2013;51(2):106–110.
   PubMed Web of Science ®Google Scholar
• Jacob J, Albert D, Heard K. Single-agent duloxetine ingestions. Hum Exp Toxicol. 2013;32(4):427–433.
   PubMedGoogle Scholar
• Brown J, Gunja N. Toxicity profile of duloxetine: a poisons centre cohort study. [abstract. ]. Clinical Toxicology. 2011;49(3):1.
   Google Scholar
• Just S, Gros S, Reichert C, et al. Duloxetine overdose: a case series. Clin Toxicol. 2015;53(4):1.
   Google Scholar
• Dunkley EJ, Isbister GK, Sibbritt D, et al. The hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96(9):635–642.
   PubMed Web of Science ®Google Scholar
• Chan A, Isbister GK, Kirkpatrick CM, et al. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. QJM. 2007;100(10):609–615.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Bowe SJ, Dawson A, et al. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol. 2004;42(3):277–285.
   PubMed Web of Science ®Google Scholar
• Hoyt BT, Rasmussen R, Giffin S, et al. Poison center data accuracy: a comparison of rural hospital chart data with the TESS database. Toxic exposure surveillance system. Acad Emerg Med. 1999;6(8):851–855.
   PubMed Web of Science ®Google Scholar
• Mari F, Gualco B, Rensi R, et al. Acute massive pulmonary thromboembolism due to acute intoxication by duloxetine: a case report. Cardiovasc Toxicol. 2012;12(3):258–262.
   PubMedGoogle Scholar
• Oliver WD, D'Angelo R, Gonzales J, et al. Acute severe hyponatremia induced by a duloxetine overdose in an elderly woman. Cureus. 2020;12(9):e10318.
   PubMedGoogle Scholar
• Scanlon KA, Stoppacher R, Blum LM, et al. Comprehensive duloxetine analysis in a fatal overdose. J Anal Toxicol. 2016;40(2):167–170.
   PubMedGoogle Scholar
• Adachi K, Beppu S, Nishiyama K, et al. Pharmacokinetics of duloxetine self-administered in overdose with quetiapine and other antipsychotic drugs in a Japanese patient admitted to hospital. J Pharm Health Care Sci. 2021;7(1):6.
   PubMedGoogle Scholar
• Alibegovic A, Kariz S, Volavsek M. Fatal overdose with a combination of SNRIs venlafaxine and duloxetine. Forensic Sci Med Pathol. 2019;15(2):258–261.
   PubMed Web of Science ®Google Scholar
• Menchetti M, Gozzi BF, Saracino MA, et al. Non-fatal overdose of duloxetine in combination with other antidepressants and benzodiazepines. World J Biol Psychiatry. 2009;10(4 Pt 2):385–389.
   PubMedGoogle Scholar
• Paulzen M, Hiemke C, Grunder G. Plasma levels and cerebrospinal fluid penetration by duloxetine in a patient with a non-fatal overdose during a suicide attempt. Int J Neuropsychopharmacol. 2009;12(10):1431–1432.
   PubMedGoogle Scholar
• Zhang L, Chappell J, Gonzales CR, et al. QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study. J Cardiovasc Pharmacol. 2007;49(3):146–153.
   PubMed Web of Science ®Google Scholar
• Gelener P, Gorgulu U, Kutlu G, et al. Serotonin syndrome due to duloxetine. Clin Neuropharmacol. 2011;34(3):127–128.
   PubMed Web of Science ®Google Scholar
• Whyte IM, Dawson AH, Buckley NA. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM. 2003; 96(5):369–374.
   PubMed Web of Science ®Google Scholar
• Pellicciari A, Balzarro B, Scaramelli A, et al. Generalized tonic-clonic seizure secondary to duloxetine poisoning: a short report with favorable outcome. Neurotoxicology. 2012;33(2):189–190.
   PubMed Web of Science ®Google Scholar
• Kumar VV, Isbister GK, Duffull SB. The effect of decontamination procedures on the pharmacodynamics of venlafaxine in overdose. Br J Clin Pharmacol. 2011;72(1):125–132.
   PubMed Web of Science ®Google Scholar
• Knadler MP, Lobo E, Chappell J, et al. Duloxetine: clinical pharmacokinetics and drug interactions. Clin Pharmacokinet. 2011;50(5):281–294.
   PubMed Web of Science ®Google Scholar
• Jasiak NM, Bostwick JR. Risk of QT/QTc prolongation among newer non-SSRI antidepressants. Ann Pharmacother. 2014;48(12):1620–1628.
   PubMedGoogle Scholar
• Isbister GK, Friberg LE, Stokes B, et al. Activated charcoal decreases the risk of QT prolongation after citalopram overdose. Ann Emerg Med. 2007;50(5):593–600.
   PubMed Web of Science ®Google Scholar
• Friberg LE, Isbister GK, Hackett LP, et al. The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach. J Pharmacokinet Pharmacodyn. 2005;32(3-4):571–605.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Friberg LE, Hackett LP, et al. Pharmacokinetics of quetiapine in overdose and the effect of activated charcoal. Clin Pharmacol Ther 2007;81(6):821–827.
   PubMed Web of Science ®Google Scholar